Published: 2019-06-29

A prospective study of the incidence and outcomes of eclampsia in a tertiary care hospital and teaching institute in India

Garima Gandhi, Kavita Chandnani


Background: Eclampsia is a common cause of maternal and foetal morbidity and mortality in India and the rest of the world accounting for nearly 10% of all maternal deaths. However, there is a relative scarcity of outcome data for patients with eclampsia in India. Our goal was to estimate the incidence of eclampsia, the maternal and foetal outcomes of patients presenting with eclampsia, and predictors of clinical outcomes in these patients. Objective of this study was to estimate the incidence of eclampsia in patients who delivered at a single tertiary care institution over a 2-year period and to study the maternal and perinatal outcomes in those patients.

Methods: Prospective cohort study conducted from September 2008 to August 2010 on all patients with eclampsia admitted during the study period at Lok Nayak Hospital, New Delhi, India.

Results: The incidence of eclampsia among total deliveries was 0.45%.  About 97% of these patients received parenteral magnesium sulphate as the primary anticonvulsant therapy. Caesarean section was performed in 22.7% and majorities were done for foetal distress. Maternal complications were encountered among 17% of patients. There were 2 maternal deaths (2.3%), 13 stillbirths (14.1%) and 7 early neonatal deaths (7.9%).

Conclusions: The incidence of eclampsia among all deliveries over a 2-year period at a tertiary care centre in India was 0.45%. Parenteral magnesium sulphate was effective in the vast majority of these patients in controlling the seizures. Further studies to evaluate whether early registration for antepartum care improves maternal and foetal outcomes in patients with eclampsia are warranted.


Eclampsia, Maternal outcome, Magnesium sulphate, Perinatal outcome

Full Text:



Duley L. Maternal mortality associated with hypertensive disorder of pregnancy in Africa, Asia, Latin America and Caribbean. Br J Obstet Gynecol. 1992;99(7):547-53.

Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ. 1994;309:1395.

Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG. 2005;112:875.

Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, León JA, et al. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol. 2011;118:987.

Tan KH, Kwek K, Yeo GS. Epidemiology of pre-eclampsia and eclampsia at the KK Women's and Children's Hospital, Singapore. Singapore Med J. 2006;47:48.

Fong A, Chau CT, Pan D, Ogunyemi DA. Clinical morbidities, trends, and demographics of eclampsia: a population-based study. Am J Obstet Gynecol. 2013;209:229.e1.

Jaatinen N, Ekholm E. Eclampsia in Finland; 2006 to 2010. Acta Obstet Gynecol Scand. 2016;95:787.

Schaap TP, van den Akker T, Zwart JJ, van Roosmalen J, Bloemenkamp KWM. A national surveillance approach to monitor incidence of eclampsia: The Netherlands Obstetric Surveillance System. Acta Obstet Gynecol Scand. 2019;98:342.

Kurude VN, Kokate PH, Saha D, Jha EK. Study of maternal and perinatal outcome in eclampsia. PIJR. 2017;6(4):63-5.

Raji C, Poovathi M, Nithya D. Prospective study of fetomaternal outcome in eclampsia in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2016;5:4329-34.

Gawandi P, Shinde MA, Jadhav CA. Clinical study of eclampsia patients at DR.V M. Government medical college Solapur, India. IOSR-JDMS, 2014;13(7):10-6.

Jain R, Bindal J. Maternal and perinatal outcomes in eclampsia: a retrospective analysis in a referral hospital. Int J Reprod Contracept Obstet Gynecol 2017;6:2806-11.

Doley R, Pegu B, Hazarika D. Clinical study of eclampsia in a tertiary care hospital. Indian J Sci Technol. 2016;9(29):1-5.

Maji B, Samanta S, Banerjee S, Hassan MT, Saharay S, Sarkar D. Clinico-epidemiological profile of eclampsia patients admitted in an urban tertiary care hospital of West Bengal: a record based study. Int J Community Med Public Health. 2018;5(6):2416-20.

Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol. 1988;158:80.

Eke AC, Ezebialu IU, Okafor C. Presentation and outcome of eclampsia at a tertiary center in South East Nigeria--a 6-year review. Hypertens Pregnancy. 2011;30:125.

Miguil M, Chekairi A. Eclampsia, study of 342 cases. Hypertens Pregnancy. 2008;27:103.

Nobis PN, Hajong A. Eclampsia in India through the decades. J Obstet Gynecol India. 2016;66(Suppl 1):172-6.

Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res. 2015;41(6):831.

Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol. 1992;167:935.

Van Weert JM, Hajenius PJ, Richard E, Wolf H, Bleker OP. Late postpartum eclampsia. Ned Tijdschr Geneeskd. 2007;151:414.

Mattar F, Sibai BM. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol. 2000;182:307.

Singhal AB, Kimberly WT, Schaefer PW, Hedley-Whyte ET. Case records of the Massachusetts General Hospital. Case 8-2009. A 36-year-old woman with headache, hypertension, and seizure 2 weeks postpartum. N Engl J Med. 2009;360:1126.

Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics,clinical course, and complications. Obstet Gynecol. 2011;118:1102.

Sibai BM. Magnesium Sulphate is the ideal anticonvulsant in preeclampsia eclampsia. Am J Obstet Gynecol. 1990;163(5Pt 1):1714-5.

Witlin AG, Sibai BM. Magnesium Sulphate therapy in preeclampsia and eclampsia. Obstet Gynecol. 1998;92(5):883-9.

Azria E, Tsat saris Y, Goffinet F, Kayem G, Mignon A, Cabrol D. Magnesium Sulphate in obstetrics: current data. J Gynecol Obstet Biol Reprod(Paris). 2004;33(6Pt 1):510-17.

Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877.

Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol. 2004;190(6):1520.

Abate M, Lakew Z. Eclampsia. A 5 years retrospective review of 216 cases managed in two teaching hospitals in Addis Adaba. Ethiop Med J. 2006;44(1):27-31.

Onuh SO, Aisian AO. Maternal and fetal outcome in eclamptic patients in Benin city, Nigeria. J Obstet Gynaecol. 2004;24(7):765-8.

Tukur J, Umar NI, Khan N, Musa D. Comparison of emergency caesarean section to misoprostol induction for the delivery of antepartum eclamptic patients: a pilot study. Niger J Med. 2007;16(4):364.

Seal SL, Ghosh D, Kamilya G, Mukherji J, Hazra A, Garain P. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol. 2012;206(6):484.e1.

Duley L, Gulmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev. 2001;CD002960.

Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2003;CD000127.

Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2003;CD000128